MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with V

Varenicline

Varenicline 1mg tablets

No stability information

Stability notes for Varenicline 1mg tablets

There are no stability notes for this medicine.

Suppliers (12) of Varenicline 1mg tablets
Champix 1mg tablets (Pfizer Ltd)
Varenicline 1mg tablets (A A H Pharmaceuticals Ltd)
Varenicline 1mg tablets (Accord-UK Ltd)
Varenicline 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Varenicline 1mg tablets (Biovantic Pharma Ltd)
Varenicline 1mg tablets (Brancaster Pharma Ltd)
Varenicline 1mg tablets (Brown & Burk UK Ltd)
Varenicline 1mg tablets (Macleods Pharma UK Ltd)
Varenicline 1mg tablets (Rudipharm Ltd)
Varenicline 1mg tablets (Teva UK Ltd)
Varenicline 1mg tablets (Umedica Laboratories UK Ltd)
Varenicline 1mg tablets (Zentiva Pharma UK Ltd)

Varenicline 1mg tablets and Varenicline 500microgram tablets

No stability information

Stability notes for Varenicline 1mg tablets and Varenicline 500microgram tablets

There are no stability notes for this medicine.

Suppliers (10) of Varenicline 1mg tablets and Varenicline 500microgram tablets
Champix 0.5mg/1mg 2 week treatment initiation pack (Pfizer Ltd)
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (A A H Pharmaceuticals Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Accord-UK Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Biovantic Pharma Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Brancaster Pharma Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Rudipharm Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Teva UK Ltd)
Varenicline 1mg tablets and Varenicline 500microgram tablets (Umedica Laboratories UK Ltd)

Varenicline 500microgram tablets

No stability information

Stability notes for Varenicline 500microgram tablets

There are no stability notes for this medicine.

Suppliers (12) of Varenicline 500microgram tablets
Champix 0.5mg tablets (Pfizer Ltd)
Varenicline 500microgram tablets (A A H Pharmaceuticals Ltd)
Varenicline 500microgram tablets (Accord-UK Ltd)
Varenicline 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Varenicline 500microgram tablets (Biovantic Pharma Ltd)
Varenicline 500microgram tablets (Brancaster Pharma Ltd)
Varenicline 500microgram tablets (Brown & Burk UK Ltd)
Varenicline 500microgram tablets (Macleods Pharma UK Ltd)
Varenicline 500microgram tablets (Rudipharm Ltd)
Varenicline 500microgram tablets (Teva UK Ltd)
Varenicline 500microgram tablets (Umedica Laboratories UK Ltd)
Varenicline 500microgram tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.